Fishing Martha's 

Vineyard 

with 

Captain Chris Peters

Baxter commences BAX 855 Phase We trial in hemophilia A Baxter International Inc.

This trial is made to provide brand-new insights about our investigational longer-performing FVIII molecule, BAX 855, with the best goal of improving look after patients coping with hemophilia A, stated Prof. Hartmut J. Ehrlich, M.D., vice president of global research and advancement in Baxter’s BioScience business. The Phase I outcomes will serve as the building blocks for advancing this essential program through clinical advancement and identifying whether BAX 855 can provide a treatment regimen needing fewer infusions than ADVATE.China’s census shows aging population; Officials say family planning policies to be maintained China’s latest census demonstrates the proportion of elderly people in the country has increased, while the proportion of young people dropped significantly, but leaders are refusing to relax strict family members planning controls that are section of the trigger, the Associated Press reports . The population of the next largest economy in the world raised by 73 million people in the last decade. According to new figures released Thursday by China’s Bureau of National Statistics, CNN reviews.